Recursion Pharmaceuticals, Inc. (RXRX)
3.28
-0.03
(-0.91%)
USD |
NASDAQ |
Apr 10, 16:00
3.30
+0.02
(+0.61%)
After-Hours: 20:00
Recursion Pharmaceuticals EPS Diluted (Quarterly) : -0.2053 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8263 |
| Tango Therapeutics, Inc. | -0.2945 |
| Geron Corp. | -0.0467 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| Quince Therapeutics, Inc. | -0.2492 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -108.12M |
| Revenue (Quarterly) | 35.54M |
| Total Expenses (Quarterly) | 143.66M |
| Enterprise Value | 1.063B |
| Gross Profit Margin (Quarterly) | 24.37% |
| Profit Margin (Quarterly) | -304.2% |
| Earnings Yield | -45.21% |
| Normalized Earnings Yield | -45.21 |